Skip to main content

The Institut Bordet Clinical Haematology Department specialises in determining and treating diseases of the blood.

The Institut Bordet is committed to the treatment of these diseases and to offering patients high-quality, individual treatment.

In addition to the traditional approach to blood diseases, the Institut is also engaged in the development of innovative and complex techniques and therapies.

The Institut’s mission covers three main university fields: clinical, research and teaching.

The multidisciplinary nature of the Department, in both its diagnostic and therapeutic approaches, forms an integral part of all decisions concerning the patient.

Research projects

Participation of the Hematology Department in research projects with the following laboratories :

EXPERIMENTAL HAEMATOLOGY LABORATORY (HEMEXP)
CLINICAL CELLULAR THERAPY RESEARCH LABORATORY (LTCC)

 

Project 1

The prognostic value of cognitive function, biomarkers of ageing and clinical factors in elderly patients with malignant haemopathy admitted for chemotherapy (Dominique Bron, MD, PhD)
  • Project leader : Dominique Bron
  • Collaborations : H. Wildiers, M. Delforge (KUL)
  • Funding : Télévie, FNRS, Fonds Yvonne Boël

Project 2

Interculturality and Transplantation  

Project 3

Role of radio-immunotherapy in myeloma

Project 4

Protocoles de recherche clinique académiques et pharmaceutiques
  • Project leaders : Dominique Bron and colleagues
  • Funding : Fonds Ariane, Pharma

Our team

Head of Department
Prof Dominique Bron - Haematological Medicine (rare lymphoma and chronic lymphoid leukaemia)

Heads of Clinic
- Prof Nathalie Meuleman - Haematological Medicine (multiple myeloma and plasmocytary disorders, autografts)
- Prof Philippe Lewalle - Haematological Medicine (myeloproliferative syndrome, chronic myeloid leukaemia and
allogeneic transplants)
- Prof Sebastian Wittnebel - Haematological Medicine (leukaemia, myelodysplasia, new drugs and
allogeneic transplants)
- Dr Marie Maerevoet - Haematological Medicine (lymphomas and lymphoproliferative disorders, new drugs,
autografts)
- Dr Cécile Springael -
Haematological Medicine (T lymphomas and rare lymphomas)

Consultant
- Dr Phuong Huynh
-
General practitioner (ability of autologous and allogeneic donors to be collected in stem cells and lymphocytes, haemovigilance)

Resident
- Dr Marie Vercruyssen - Haematological Medicine (multiple myeloma and plasmocytic disorders, autografts)
- Dr Chloé Spilleboudt
Haematological Medicine (leukemias, myelodysplasias and allogeneic transplantations)
- Dr
Adriano SalaroliHaematological Medicine (myeloproliferative syndromes, chronic myeloid leukemia, leukemia, myelodysplasia and allogeneic transplantation)

Head Nursing (Tel : +32 (0)2 541 33 55)
Patrick Crombez

Nursing «coordinator of allografts » (Tel : +32 (0)2 541 33 30)
- Marie-France Jaivenois

Nurses (health care coordinators) (Tel : +32 (0)2 541 73 94)
- Sophie Delaunois
- Zilfi Balci

Cytapheresis unit and Stem Cell Collection (Tel : +32 (0)2 541 32 11)
Philippe Lewalle - Responsible physician
- Adriano Salaroli - Resident
- Corine Mal - Nurse
- Walter Bellemans - Nurse
- Munteanu Nicoleta - Nurse
- Olivier Mugema - Nurse

Transplantation Coordination (Tel : +32 (0)2 541 32 12)
- Sandra Michiels - Coordinator
- Redouane Rouas - Suppleant

Data Managing Unit
- Anne De Meuter - Head Nurse (Tel : +32 (0)2 541 72 05)
- Dominique De Poorter - Nurse (Tel : +32 (0)2 541 35 98)
- Sabrina Costantini - Administrative (Tel : +32 (0)2 541 37 55)
- Delphine Leva - Administrative (Tel : +32 (0)2 541 33 57)
- Gregory Rios - Nurse (Tel : +32 (0)2 541 36 47)

Quality Cell
- Aurélie Timmermans (Tel +32 (0)2 541 72 25)
-
 Olivier Carabin (Tel +32 (0)2 541 37 26)

Secretariat 
- Sabine Ackermans (Administration) - Tel : +32 (0)2 541 37 28
- Jennifer Marinus (Consultation) - Tel : +32 (0)2 541 36 84
- Nancy Martin (Consultation) - Tel : +32 (0)2 541 38 78

 Scientific publications

Mesenchymal stromal cells and natural killer cells: a complex story of love and hate.

Authors : Najar M, Fayyad-Kazan M, Merimi M, Burny A, Bron D, Fayyad-Kazan H, Meuleman N, Lagneaux L
Year : 2019
Journal : Curr Stem Cell Res Ther
Volume : 14(1)
Pages : 14-21

Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study.

Authors : Houot R, Cartron G, Bijou F, de Guibert S, Salles GA, Fruchart C, Bouabdallah K, Maerevoet M, Feugier P, Le Gouill S, Tilly H, Casasnovas RO, Moluçon-Chabrot C, Van Den Neste E, Zachee P, Andre M, Bonnet C, Haioun C, van Hoof A, Van Eygen K, Molina L, Nicolas-Virelizier E, Ruminy P, Morschhauser F
Year : 2019
Journal : Leukemia
Volume : 33
Pages : 776-780

MiR302c, Sp1, and NFATc2 regulate interleukin-21 expression in human CD4+CD45RO+ T lymphocytes.

Authors : El-Said H, Fayyad-Kazan M, Aoun R, Borghol N, Skafi N, Rouas R, Vanhamme L, Mourtada M, Ezzeddine M, Burny A, Fayyad-Kazan H, Badran B
Year : 2019
Journal : J Cell Physiol
Volume : 234
Pages : 5998-6011

Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery.

Authors : Quinten C, Kenis C, Decoster L, Debruyne PR, De Groof I, Focan C, Cornelis F, Verschaeve V, Bachmann C, Bron D, Luce S, Debugne G, Van den Bulck H, Goeminne JC, Baitar A, Geboers K, Petit B, Langenaeken C, Van Rijswijk R, Specenier P, Jerusalem G, Praet JP, Vandenborre K, Lycke M, Flamaing J, Milisen K, Lobelle JP, Wildiers H
Year : 2019
Journal : Qual Life Res
Volume : 28
Pages : 663-676

Sweet's syndrome induced by pegfilgrastim during a myelodysplastic syndrome AREB2: A case report.

Authors : Nelis S, Azerad MA, Drowart A, Lewalle P, Efira A
Year : 2019
Journal : Rev Med Interne
Volume : 40
Pages : 258-261

Follow us!

Support research

Support research

Research at the Institut Jules Bordet depends on your generosity. Make a donation today and join us in the fight against cancer.

Learn more